Skip to content Skip to footer
VIEWPOINTS_Paul K Owens_2023

Paul K Owens, VP of Global Brand Development, Insulins & Glucagon at Eli Lilly & Company Shares Insights from the US FDA Approval of Lyumjev

Shots:Paul talked about the approval of the Lyumjev Injection for the improvement of glycemic control in children and adolescents with diabetes. He also shared various details about LyumjevPaul further discussed the study design and the key findings from the registrational PRONTO-Peds studyThe interview also talks about Lilly’s Diabetes Solution Center which helps eligible…

Read more